4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-053647
CFO & Executive Vice President sold 3,484 shares at $38.22 ($133,158)
From the SEC's structured data for this filing
Trades in this filing
Dier Mardi · CFO & Executive Vice President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-12 | Sale : show line 1 in the form | −3,484 | $38.22 | $133,158 | 68,324 | D |
| Open-market sales · 3,484 sh · avg $38.22 · $133,158 | ||||||
Loading xslF345X03/doc4.xml…